Format

Send to

Choose Destination
See comment in PubMed Commons below
FEBS Lett. 2009 Jun 5;583(11):1766-71. doi: 10.1016/j.febslet.2009.03.031. Epub 2009 Mar 20.

Functional genomics and proteomics approaches to study the ERBB network in cancer.

Author information

1
Division of Molecular Genome Analysis, German Cancer Research Center, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany. oe.sahin@dkfz.de

Abstract

Substantial progress in functional genomic and proteomic technologies has opened new perspectives in biomedical research. The sequence of the human genome has been mostly determined and opened new visions on its complexity and regulation. New technologies, like RNAi and protein arrays, allow gathering knowledge beyond single gene analysis. Increasingly, biological processes are studied with systems biological approaches, where qualitative and quantitative data of the components are utilized to model the respective processes, to predict effects of perturbations, and to then refine these models after experimental testing. Here, we describe the potential of applying functional genomics and proteomics, taking the ERBB family of growth-factor receptors as an example to study the signaling network and its impact on cancer.

PMID:
19303877
DOI:
10.1016/j.febslet.2009.03.031
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center